Emergent BioSolutions sees 2006 revenue above analysts' view

Jan 8 (Reuters) - Biopharmaceutical company Emergent BioSolutions Inc. (EBS.N) forecast 2006 revenue above analysts' estimates.

The company said it expects total revenue for 2006 to be about $150 million. Analysts, on average, expect revenue of $144.5 million for the year, according to Reuters Estimates. (Reporting by Dhanya Skariachan in Bangalore)